Pramlintide Su sodium 4C7H8O3S/c1-49-21-13-29(14-22-49)41-33-5-7-35(45-33)42(30-15-23-50(2)24-16-30)37-9-11-39(47-37)44(32-19-27-52(4)28-20-32)40-12-10-38(48-40)43(36-8-6-34(41)46-36)31-17-25-51(3)26-18-31

4C7H8O3S/c1-49-21-13-29(14-22-49)41-33-5-7-35(45-33)42(30-15-23-50(2)24-16-30)37-9-11-39(47-37)44(32-19-27-52(4)28-20-32)40-12-10-38(48-40)43(36-8-6-34(41)46-36)31-17-25-51(3)26-18-31

to a lesser degree

Antisauvagine-30 (aSvg-30) injected i

InChi: InChI=1S/C18H29NO2/c1-18(2

7 mg/mL (90

Pramlintide Su sodium 4C7H8O3S/c1-49-21-13-29(14-22-49)41-33-5-7-35(45-33)42(30-15-23-50(2)24-16-30)37-9-11-39(47-37)44(32-19-27-52(4)28-20-32)40-12-10-38(48-40)43(36-8-6-34(41)46-36)31-17-25-51(3)26-18-31Pramlintide is a polypeptide analogue of human amylin. Pramlintide, an antidiabetic agent, is antineoplastic in colorectal cancer. Product information CAS Number: 151126 32 8 Molecular Weight: 3949. 39 Formula: C171H267N51O53S2 Chemical Name: (2S) N [(1S) 4 carbamimidamido 1 {[(1S) 1 {[(1S) 1 {[(1S) 2 carbamoyl 1 {[(1S) 1 {[(1S) 1 {[(1S) 1 {[(1S) 1 {[(1S) 1 {[(1S) 1 {[(1S) 2 carbamoyl 1 {[(1S) 2 carbamoyl 1 {[(1S) 1 ({2 [(2S) 2 {[(1S,2S) 1 {[(2S) 1